Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Weight loss drugs can boost testosterone in men, study finds
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, according to new research. Read More
Revealed: How popular weight loss drug may lower dementia and stroke risk

Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ... Read More
Weight-Loss Drugs May Lower Risk Of Obesity-Related Cancers

By Dennis Thompson HealthDay ReporterWEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic and Zepbound can help reduce a woman’s risk for as many as 14 ... Read More
Weight-loss drugs’ impact on cancer risk revealed in new study

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 RAs may help prevent the disease. Read More
Weight-loss drugs may lower cancer risk in people with diabetes, a ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. How to ... Read More
Could weight loss drugs help prevent cancer? Here's what a new study ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes. Read More
Popular weight-loss drugs show promising new power against debilitating migraines
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes. Read More
For diabetics, weight-loss drugs might lessen cancer risk, study finds ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with diabetes took the blockbuster drugs, including Wegovy, Ozempic and Zepbound. Read More
Weight loss drugs cut cancer risk by 50% in 'transformational' new study

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery. Read More
Weight-Loss Drugs May Lower Cancer Risk In People With Diabetes, A ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a study ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus